Publication:
Nasopharyngeal Metastasis From Uterine Leiomyosarcoma

dc.authorscopusid58945414900
dc.authorscopusid36702709300
dc.authorscopusid26638181300
dc.authorscopusid56060485500
dc.contributor.authorIşik Bayraktar, D.
dc.contributor.authorDemirag̈, G.
dc.contributor.authorGün, S.
dc.contributor.authorCamlıdag, İ.
dc.date.accessioned2025-12-11T01:45:28Z
dc.date.issued2024
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Işik Bayraktar] Demet, Division of Medical Oncology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Demirag̈] Güzin Gonullu, Division of Medical Oncology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Gün] Seda, Department of Pathology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Camlıdag] İlkay, Department of Radiology, Ondokuz Mayis University, Medical School, Samsun, Turkeyen_US
dc.description.abstractUterine leiomyosarcoma constitutes one of the rare gynecological cancers and contributes to less than 1% of female genital tract cancers. Being one of the rare sites for metastasis development, metastasis of uterine neoplasms in the nasopharyngeal region is extremely rare. A 53-year-old multiparous woman with FIGO Stage Ib uterine leiomyosarcoma presented with nasal congestion 1 year following primary treatment. Paranasal computed tomography revealed a nasopharyngeal mass. The immunohistochemical study demonstrated that tumor cells were stained negative for desmin, h-caldesmon, and estrogen receptor, and were positive for p16 and Ki67. The proliferative index was 50 to 60%, confirming the nasopharyngeal metastasis of uterine leiomyosarcoma. No distant metastasis or local recurrence was evident in her systemic radiological evaluation. The patient received curative radiotherapy after nasopharyngeal mass excision, following which systemic chemotherapy was initiated. After the completion of treatment, the patient was followed for 9 months without recurrence or metastasis. These findings demonstrated that local treatments for metastases will contribute to patient survival. © 2024 by Turkish Society of Medical Oncology.en_US
dc.identifier.doi10.37047/jos.2023-98802
dc.identifier.endpage68en_US
dc.identifier.issn2452-3364
dc.identifier.issn2651-4532
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85188081349
dc.identifier.scopusqualityQ4
dc.identifier.startpage65en_US
dc.identifier.trdizinid1281508
dc.identifier.urihttps://doi.org/10.37047/jos.2023-98802
dc.identifier.urihttps://search.trdizin.gov.tr/en/yayin/detay/1281508/nasopharyngeal-metastasis-from-uterine-leiomyosarcoma
dc.identifier.urihttps://hdl.handle.net/20.500.12712/45988
dc.identifier.volume10en_US
dc.language.isoenen_US
dc.publisherTurkiye Kliniklerien_US
dc.relation.ispartofJournal of Oncological Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectLeiomyosarcomaen_US
dc.subjectNasopharyngeal Metastasisen_US
dc.subjectUterine Leiomyosarcomaen_US
dc.titleNasopharyngeal Metastasis From Uterine Leiomyosarcomaen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files